Randomized Clinical Trial of Cognitive Behavioral Stress Management on Human Immunodeficiency Virus Viral Load in Gay Men Treated With Highly Active Antiretroviral Therapy
Michael H. Antoni, PhD,
Adam W. Carrico, MS,
Ron E. Durán, PhD,
Susan Spitzer, PhD,
Frank Penedo, PhD,
Gail Ironson, MD, PhD,
Mary Ann Fletcher, PhD,
Nancy Klimas, MD and
Neil Schneiderman, PhD
From the Department of Psychology (M.H.A., A.W.C., R.E.D., S.S., F.P., G.I., N.S.), Department of Psychiatry (M.H.A., G.I., N.S.), and Department of Medicine (M.A.F., N.K., N.S.), University of Miami, Coral Gables, FL.

View larger version (29K):
[in a new window]
|
Figure 1. Participant flow diagram for the present randomized clinical trial.
|
|

View larger version (14K):
[in a new window]
|
Figure 2. Predicted change in log10 HIV viral load throughout the investigation period in HIV+ men assigned to CBSM + MAT versus those assigned to MAT-Only.
|
|

View larger version (32K):
[in a new window]
|
Figure 3. Structural equation model explaining associations between changes in depressed mood, medication adherence, and HIV viral load over the study period. The model explained 86.3% of the variance in slope of HIV viral load over the 15-month investigation period. Parameter estimates are unstandardized.
|
|
Copyright © 2006 by the American Psychosomatic Society